Stock listing
Dusseldorf:0G4 Bioceres Crop Solutions Corp. Aktie
German listing (Dusseldorf) of Bioceres Crop Solutions Corp. · home listing NASDAQ:BIOX
Follow Bioceres Crop Solutions Corp. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BIOX
$0.173 USD -0.028 (-13.9%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BIOX
- Day range
- $0.162 – $0.180 USDNov 20, 2026
- Volume
- 130,225 sharesNov 20, 2026
- Market cap
- $11.04M USDAt the close on Nov 20, 2026 · price × 63.82M shares outstanding
- 52-week range
- $0.162 – $1.732 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $110,596 USDMedian day 179,414 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BIOX · Home | $0.173 USD | -0.028 (-13.9%) | 130,225 | $0.180 | $0.180 | $0.162 | $0.201 | Close on Nov 20, 2026 |
| Frankfurt:0G4 | €0.142 EUR | -0.016 (-10.1%) | — | €0.135 | €0.142 | €0.135 | €0.158 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BIOX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.173 | -0.028 | -13.9% | $0.180 | $0.180 | $0.162 | 130,225 | |
| $0.201 | +0.011 | +5.7% | $0.203 | $0.207 | $0.200 | 190,730 | |
| $0.190 | -0.010 | -4.8% | $0.200 | $0.210 | $0.181 | 176,063 | |
| $0.200 | -0.010 | -4.9% | $0.209 | $0.217 | $0.195 | 182,981 | |
| $0.210 | -0.012 | -5.4% | $0.216 | $0.228 | $0.210 | 85,497 | |
| $0.222 | -0.011 | -4.6% | $0.219 | $0.244 | $0.206 | 145,490 | |
| $0.233 | +0.018 | +8.5% | $0.222 | $0.240 | $0.210 | 93,482 | |
| $0.215 | -0.023 | -9.6% | $0.237 | $0.240 | $0.212 | 62,971 | |
| $0.237 | +0.003 | +1.4% | $0.235 | $0.260 | $0.213 | 124,503 | |
| $0.234 | +0.022 | +10.2% | $0.226 | $0.259 | $0.211 | 244,815 | |
| $0.213 | -0.041 | -16.1% | $0.254 | $0.254 | $0.210 | 193,506 | |
| $0.253 | +0.027 | +12.0% | $0.228 | $0.257 | $0.213 | 297,852 | |
| $0.226 | +0.005 | +2.0% | $0.226 | $0.240 | $0.220 | 138,934 | |
| $0.222 | +0.014 | +6.6% | $0.215 | $0.230 | $0.205 | 432,160 | |
| $0.208 | -0.022 | -9.4% | $0.230 | $0.230 | $0.206 | 123,923 | |
| $0.230 | -0.019 | -7.8% | $0.242 | $0.249 | $0.211 | 199,152 | |
| $0.249 | +0.011 | +4.8% | $0.230 | $0.255 | $0.201 | 378,812 | |
| $0.237 | +0.034 | +16.9% | $0.210 | $0.239 | $0.203 | 246,618 | |
| $0.203 | -0.032 | -13.5% | $0.228 | $0.239 | $0.201 | 387,510 | |
| $0.235 | -0.020 | -8.0% | $0.260 | $0.272 | $0.190 | 549,138 | |
| $0.255 | +0.010 | +4.1% | $0.242 | $0.274 | $0.242 | 151,185 | |
| $0.245 | -0.007 | -2.7% | $0.259 | $0.260 | $0.234 | 179,414 | |
| $0.252 | -0.003 | -1.3% | $0.260 | $0.260 | $0.240 | 233,456 | |
| $0.255 | -0.021 | -7.6% | $0.287 | $0.287 | $0.253 | 263,279 | |
| $0.276 | -0.018 | -6.1% | $0.290 | $0.306 | $0.261 | 334,000 | |
| $0.294 | -0.006 | -2.0% | $0.300 | $0.322 | $0.280 | 251,200 | |
| $0.300 | -0.025 | -7.7% | $0.325 | $0.333 | $0.300 | 239,800 | |
| $0.325 | -0.006 | -1.8% | $0.330 | $0.335 | $0.321 | 31,200 | |
| $0.331 | +0.003 | +0.9% | $0.330 | $0.335 | $0.320 | 110,100 | |
| $0.328 | 0.000 | 0.0% | $0.327 | $0.335 | $0.320 | 127,300 | |
| $0.328 | -0.007 | -2.1% | $0.321 | $0.337 | $0.321 | 55,100 | |
| $0.335 | -0.005 | -1.5% | $0.340 | $0.346 | $0.323 | 131,300 | |
| $0.340 | -0.006 | -1.7% | $0.327 | $0.351 | $0.327 | 93,100 | |
| $0.346 | +0.004 | +1.2% | $0.340 | $0.356 | $0.315 | 288,300 | |
| $0.342 | -0.007 | -2.0% | $0.344 | $0.360 | $0.340 | 73,400 | |
| $0.349 | +0.001 | +0.3% | $0.350 | $0.358 | $0.347 | 34,800 | |
| $0.348 | +0.002 | +0.6% | $0.348 | $0.359 | $0.334 | 56,600 | |
| $0.346 | -0.012 | -3.4% | $0.374 | $0.374 | $0.335 | 185,000 | |
| $0.358 | -0.016 | -4.3% | $0.364 | $0.384 | $0.350 | 39,000 | |
| $0.374 | +0.003 | +0.8% | $0.374 | $0.380 | $0.358 | 73,300 | |
| $0.371 | -0.021 | -5.4% | $0.381 | $0.386 | $0.351 | 239,100 | |
| $0.392 | +0.032 | +8.9% | $0.351 | $0.394 | $0.330 | 413,800 | |
| $0.360 | +0.001 | +0.3% | $0.359 | $0.361 | $0.321 | 633,900 | |
| $0.359 | -0.001 | -0.3% | $0.369 | $0.377 | $0.348 | 433,400 | |
| $0.360 | -0.008 | -2.2% | $0.400 | $0.400 | $0.343 | 809,100 | |
| $0.368 | -0.018 | -4.7% | $0.391 | $0.398 | $0.353 | 313,300 | |
| $0.386 | -0.019 | -4.7% | $0.408 | $0.413 | $0.372 | 127,200 | |
| $0.405 | -0.023 | -5.4% | $0.406 | $0.430 | $0.365 | 821,700 | |
| $0.428 | +0.009 | +2.1% | $0.440 | $0.440 | $0.411 | 275,600 | |
| $0.419 | -0.004 | -0.9% | $0.411 | $0.440 | $0.410 | 63,500 | |
| $0.423 | -0.003 | -0.7% | $0.413 | $0.430 | $0.410 | 66,700 | |
| $0.426 | +0.004 | +0.9% | $0.431 | $0.440 | $0.425 | 75,900 | |
| $0.422 | -0.012 | -2.8% | $0.421 | $0.450 | $0.410 | 164,000 | |
| $0.434 | +0.015 | +3.6% | $0.429 | $0.446 | $0.410 | 70,300 | |
| $0.419 | -0.028 | -6.3% | $0.434 | $0.450 | $0.411 | 162,200 | |
| $0.447 | -0.013 | -2.8% | $0.445 | $0.470 | $0.429 | 197,900 | |
| $0.460 | +0.030 | +7.0% | $0.414 | $0.460 | $0.410 | 500,800 | |
| $0.430 | +0.020 | +4.9% | $0.410 | $0.573 | $0.400 | 5,735,300 | |
| $0.410 | +0.006 | +1.5% | $0.404 | $0.430 | $0.400 | 148,400 | |
| $0.404 | -0.012 | -2.9% | $0.411 | $0.425 | $0.400 | 93,400 | |
| $0.416 | -0.004 | -1.0% | $0.413 | $0.444 | $0.404 | 63,100 | |
| $0.420 | +0.008 | +1.9% | $0.410 | $0.450 | $0.401 | 254,400 | |
| $0.412 | -0.029 | -6.6% | $0.440 | $0.450 | $0.400 | 211,400 | |
| $0.441 | -0.009 | -2.0% | $0.461 | $0.480 | $0.420 | 825,000 | |
| $0.450 | +0.035 | +8.4% | $0.409 | $0.450 | $0.400 | 124,000 |
- Ticker
- Dusseldorf:0G4
- Asset type
- Stock
- Sector
- Chemicals & materials
- Industry
- Fertilizers & crop chemicals
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Nov 11, 2026
Bioceres Crop Solutions Reports Fiscal First Quarter 2027 Financial and Operational Results
Latest earnings call · Sep 15, 2026
Bioceres Crop Solutions (NASDAQ:BIOX) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Sep 15, 2026
Q4 2026 Earnings Presentation
Earnings · 17 slides
Latest news
Bioceres Crop Solutions Reports Fiscal First Quarter 2027 Financial and Operational Results
Nov 11, 2026
Closed $0.222 (-4.6%) on Nov 12, 2026
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
Sep 14, 2026
Closed $0.405 (-5.4%) on Sep 15, 2026
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8: 30 a.m. Eastern Time
Sep 9, 2026
Closed $0.423 (-0.7%) on Sep 10, 2026
Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results
May 11, 2026
Closed $0.451 (-16.9%) on May 12, 2026
CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8: 30 a.m. Eastern Time
May 5, 2026
Closed $0.469 (+4.9%) on May 5, 2026
A Message from Our Chief Executive Officer
Mar 16, 2026
Closed $0.435 (-17.5%) on Mar 16, 2026
Bioceres Crop Solutions Corp. on 6ix
- Sector
- Chemicals & materials
- Industry
- Fertilizers & crop chemicals
- News releases
- 7 in the last 12 months · 85 in all · newest Nov 11, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Sep 15, 2026
- Decks
- 37 decks · latest Sep 15, 2026
Where Bioceres Crop Solutions Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BIOX · Home listing | NASDAQ | United States | USD |
| BCBA:BIOX | BCBA | Argentina | ARS |
| BCBA:BIOXD | BCBA | Argentina | USD |
| BCBA:BIOXC | BCBA | Argentina | USD |
| BOATS:BIOX | BOATS | United States | USD |
| LS Exchange:A2PTXR | LS Exchange | Germany | EUR |
| gettex:0G4 | gettex | Germany | EUR |
| Lang & Schwarz:A2PTXR | Lang & Schwarz | Germany | EUR |
| BCBA:BIOXB | BCBA | Argentina | ARS |
| Dusseldorf:0G4 · This page | Dusseldorf | Germany | EUR |
| Frankfurt:0G4 | Frankfurt | Germany | EUR |
| Hamburg:0G4 | Hamburg | Germany | EUR |
| Munich:0G4 | Munich | Germany | EUR |
| Stuttgart:0G4 | Stuttgart | Germany | EUR |
Valuation
EV/sales 1.0× against a median of 0.5×: 7th lowest of 9 Fertilizers & crop chemicals companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $235.6M USD
- P/E
- Loss
- EV/sales
- 1.0×
- EV/EBITDA
- 14.8×
- Price/book
- 0.3×
- Gross margin
- 34.6%
- Operating margin
- 0.0%
- Net margin
- −96.9%
- Debt to equity
- 6.1×
- Beta vs S&P 500
- 2.17
Fertilizers & crop chemicals: the 10 companies nearest in size, of 113 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bioceres Crop Solutions Corp. · NASDAQ:BIOX | US$11.04M | US$235.6M | n/a | 1.0× | 14.8× | 0.3× | −96.9% | 6.1× | 2.17 |
| Fertilizantes Heringer S.A. · BMFBOVESPA:FHER3 | US$23.07M | US$103.8M | n/a | 0.2× | n/a | n/a | −6.8% | n/a | n/a |
| Nova Agritech Limited · NSE:NOVAAGRI | US$21.64M | US$21.64M | 15.6× | 0.7× | 5.5× | 0.9× | 4.7% | 0.0× | n/a |
| American Vanguard Corporation · NYSE:AVD | US$20.10M | US$203.9M | n/a | 0.4× | n/a | 0.1× | −12.0% | 1.6× | 1.09 |
| Tianjin TEDA Biomedical Engineering Co. Ltd. Class H · HKEX:8189 | US$19.42M | US$25.95M | n/a | 0.2× | n/a | 5.8× | −12.5% | 4.8× | n/a |
| Verde AgriTech Ltd · TSX:NPK | US$18.11M | US$53.96M | n/a | 6.6× | n/a | 1.6× | −118.4% | 3.5× | 1.23 |
| Southern Fertilizer Joint Stock Company · HOSE:SFG | US$16.77M | −US$3.48M | 13.4× | −0.0× | −1.1× | 0.6× | 1.6% | 0.0× | n/a |
| Atome PLC · LSE:ATOM | US$15.08M | US$10.79M | n/a | n/a | n/a | 0.8× | n/a | 0.2× | n/a |
| MustGrow Biologics Corp. · TSXV:MGRO | US$13.26M | US$10.30M | n/a | 4.6× | n/a | 3.8× | −174.4% | 0.0× | 0.76 |
| RLF AgTech Ltd · ASX:RLF | US$11.02M | US$9.81M | n/a | 0.6× | n/a | 2.0× | −27.8% | 0.6× | n/a |
| Nagarjuna Fertilizers & Chemicals Ltd. · NSE:NAGAFERT | US$8.58M | US$8.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Median of the others | US$17.44M | US$16.21M | 14.5× | 0.5× | 2.2× | 1.3× | −12.2% | 0.4× | 1.09 |
Forecasts
Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.
- Price target
- 2.00 USD · Analysts' mean
- EPS, year to Jun 2026
- -0.16 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Federico Trucco | Executive Director |
Board
| Director | Role |
|---|---|
| Duraiswami Narain | Non-Executive Director |
| Federico Trucco | Executive Director |
| Simon Vumbaca | Non-Executive Director |
| Yogesh Mago | Non-Executive Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Bioceres Crop Solutions (NASDAQ:BIOX) Q4 2026 Earnings Call | Tue, Sep 15, 2026 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q3 2026 Earnings Call | Tue, May 12, 2026 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q1 2026 Earnings Call | Thu, Nov 13, 2025 · 3:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q4 2025 Earnings Call | Tue, Sep 09, 2025 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q3 2025 Earnings Call | Wed, May 21, 2025 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q2 2025 Earnings Call | Wed, Feb 12, 2025 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q1 2025 Earnings Call | Tue, Nov 12, 2024 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q4 2024 Earnings Call | Tue, Sep 10, 2024 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q3 2024 Earnings Call | Tue, May 14, 2024 · 8:30 AM ET | Replay |
| Bioceres Crop Solutions (NASDAQ:BIOX) Q2 2024 Earnings Call | Thu, Feb 08, 2024 · 4:30 PM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 11, 2026 | +3.5% |
| Q4 2026 | Sep 14, 2026 · After close | −5.4% |
| Q3 2026 | May 11, 2026 · After close | −16.9% |
| Q2 2026 | Feb 25, 2026 | −3.5% |
| Q1 2026 | Nov 12, 2025 | −11.4% |
| Q4 2025 | Sep 9, 2025 · Before open | −16.1% |
| Q3 2025 | May 21, 2025 · Before open | −4.3% |
| Q2 2025 | Feb 11, 2025 · After close | −13.9% |
| Q1 2025 | Nov 11, 2024 · After close | +2.7% |
| Q4 2024 | Sep 9, 2024 · After close | −13.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | May 13, 2024 · After close | −2.8% |
| Q2 2024 | Feb 8, 2024 · After close | +6.7% |
| Q1 2024 | Nov 13, 2023 · After close | +5.0% |
| Q4 2023 | Sep 11, 2023 · After close | −6.0% |
| Q3 2023 | May 10, 2023 · After close | +9.1% |
| Q2 2023 | Feb 8, 2023 · After close | −7.5% |
| Q1 2023 | Nov 29, 2022 · After close | +2.8% |
| Q4 2022 | Sep 8, 2022 · Before open | −3.8% |
| Q3 2022 | May 27, 2022 · After close | +1.7% |
| Q2 2022 | Feb 25, 2022 · After close | +11.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2026 Earnings Presentation | Earnings | 17 slides | Sep 15, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 16 slides | May 12, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 13 slides | Nov 13, 2025 |
| Q4 2025 Earnings Presentation | Earnings | 16 slides | Sep 9, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 18 slides | May 21, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 20 slides | Feb 12, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 15 slides | Nov 12, 2024 |
| Q4 2024 Earnings Presentation | Earnings | 18 slides | Sep 10, 2024 |
| Q3 2024 Earnings Presentation | Earnings | 18 slides | May 14, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 15 slides | Feb 8, 2024 |
All 37 decks
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 237.8M | 335.1M | 464.8M | 420.1M | 334.8M | 209.5M | 173.1M | 160.6M | 133.5M | 93.7M |
| Cost of revenue | 155.4M | 203.4M | 278.2M | 235.5M | 208.4M | 118.6M | 93.6M | 87.0M | 77.1M | 59.9M |
| Gross profit | 82.4M | 131.7M | 186.6M | 184.6M | 126.5M | 90.9M | 79.5M | 73.6M | 56.4M | 33.8M |
| Research and development | 11.0M | 14.9M | 17.2M | 15.3M | 6.95M | 5.62M | 4.20M | 3.69M | 3.95M | 3.98M |
| Selling, general and administrative | 49.3M | 123.1M | 123.7M | 113.0M | 77.5M | 47.6M | 38.3M | 39.2M | 35.3M | 25.3M |
| Operating income | 100.0K | -2.24M | 45.9M | 54.2M | 39.9M | 38.4M | 39.1M | 32.1M | 15.7M | -706.9K |
| Depreciation and amortization | 15.8M | 5.99M | 5.76M | 4.83M | 3.77M | 3.05M | 2.01M | 2.45M | 2.23M | 4.61M |
| EBITDA | 15.9M | 3.75M | 51.6M | 59.0M | 43.6M | 41.4M | 41.2M | 34.5M | 17.9M | 3.90M |
| Interest expense | 50.9M | 28.8M | 26.9M | 23.8M | 17.9M | 21.2M | 20.9M | 23.4M | 17.2M | 14.9M |
| Income before tax | -51.0M | -57.6M | 11.1M | 19.1M | 14.1M | 10.5M | 6.44M | -9.37M | -25.2M | -22.4M |
| Income tax | 3.40M | 1.27M | 3.78M | -1.07M | 18.0M | 14.4M | 2.21M | 6.99M | -10.9M | -5.63M |
| Net income | -230.3M | -55.4M | 4.28M | 18.8M | -7.20M | -6.87M | 3.36M | -18.4M | -11.0M | -11.8M |
| Earnings per share, basic | -3.62 | -0.88 | 0.07 | 0.30 | -0.17 | -0.18 | 0.09 | -0.60 | -0.39 | -0.42 |
| Earnings per share, diluted | -0.88 | 0.07 | 0.30 | -0.17 | -0.18 | 0.09 | -0.60 | -0.39 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.2M | 32.7M | 44.5M | 48.1M | 33.5M | 36.0M | 42.5M | 3.45M | 2.22M | 1.68M |
| Short-term investments | 1.00M | 2.04M | 11.7M | 11.9M | 5.14M | 10.7M | 28.8M | 356.2K | 12.5K | 4.28K |
| Receivables | 111.7M | 165.9M | 207.3M | 158.0M | 111.8M | 88.8M | 73.5M | 59.2M | 52.9M | 41.7M |
| Inventory | 46.7M | 87.6M | 125.9M | 140.4M | 126.0M | 61.0M | 29.3M | 27.3M | 19.4M | 31.3M |
| Current assets | 215.2M | 308.3M | 408.7M | 397.1M | 297.7M | 211.5M | 164.7M | 98.2M | 85.3M | 87.8M |
| Property, plant and equipment | 74.6M | 74.6M | 67.9M | 49.9M | 48.0M | 41.5M | 43.8M | 40.2M | 46.2M | |
| Goodwill | 36.1M | 112.2M | 112.2M | 112.2M | 36.1M | 28.8M | 25.5M | 29.8M | 14.4M | 25.1M |
| Total assets | 471.3M | 763.6M | 852.5M | 818.1M | 518.2M | 394.6M | 297.6M | 242.5M | 196.6M | 239.9M |
| Accounts payable | 57.6M | 96.4M | 168.7M | 150.8M | 125.8M | 72.1M | 57.3M | 40.6M | 27.7M | 22.3M |
| Current liabilities | 267.0M | 338.0M | 329.3M | 298.7M | 222.7M | 168.0M | 130.6M | 116.5M | 118.7M | 69.4M |
| Long-term debt | 60.0M | 38.2M | 42.1M | 60.7M | 74.2M | 48.0M | 41.2M | 37.1M | 25.7M | 41.0M |
| Total debt | 236.8M | 157.9M | 178.9M | 168.3M | 145.5M | 124.8M | 10.4M | 103.6M | 91.0M | 75.0M |
| Total liabilities | 407.2M | 468.4M | 501.2M | 487.6M | 359.9M | 304.3M | 236.8M | 180.4M | 163.5M | 160.1M |
| Shareholders' equity | 39.1M | 265.4M | 315.0M | 298.6M | 127.4M | 67.7M | 46.2M | 47.3M | 13.7M | 38.3M |
| Shares outstanding | 63.6M | 63.2M | 63.5M | 63.2M | 42.3M | 39.2M | 36.4M | 30.5M | 28.1M | 28.1M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 52.6M | 49.9M | 41.7M | 2.59M | -17.5M | -6.21M | 9.32M | 29.7M | 18.4M | 19.1M |
| Capital spending | -1.05M | -5.64M | -9.79M | -11.4M | -3.46M | -2.81M | -1.65M | -2.04M | -2.79M | -1.39M |
| Free cash flow | 51.6M | 44.3M | 31.9M | -8.77M | -21.0M | -9.01M | 7.67M | 27.7M | 15.6M | 17.7M |
| Cash from investing | -5.86M | -6.13M | -28.7M | -25.7M | 2.90M | -8.31M | -7.80M | -3.26M | -8.22M | -20.2M |
| Cash from financing | -65.3M | -50.7M | -10.1M | 33.0M | 14.8M | 7.36M | 33.5M | -26.9M | -10.5M | 2.33M |
| Dividends paid | 0 | -72.1K | -174.8K | -452.1K | 0 | -1.03M | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | -926.9K | -734.4K | -3.00M | -3.00M | -3.50M | -30.9K | -30.9K | 0 | 0 |
| Change in cash | -21.5M | -6.93M | 2.93M | 9.82M | 211.2K | -7.16M | 35.0M | -512.2K | -290.6K | 1.39M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Nov 17, 2026 | Current report | SEC |
| 20-F · Annual report | Oct 30, 2026 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Sep 21, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 15, 2026 | Current report | SEC |
| 4/A · Change in ownership, amended | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jul 7, 2026 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Jun 22, 2026 | Current report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 1, 2026 | Big-stake notice | SEC |
Show 200 filings
This page holds 200 of 281 filings. Open Filings
Cap table
Built by 6ix from Bioceres Crop Solutions Corp.’s releases
- Common shares
- 63,815,891
- Fully diluted
- 63,815,891
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 63,815,891 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 63,815,891 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Yogesh Mago Other companies: Marrone Bio Innovations Inc (Director · Feb 5, 2018 – Jul 12, 2022 · Past) | Non-Executive Director · Since at least May 11, 2026 |
| Duraiswami Narain | Non-Executive Director · Since at least Nov 5, 2026 |
| Ezequiel Simmermacher | CFO · Since at least Dec 31, 2025 |
| Federico Trucco | CEO, Director · Since at least May 11, 2026 |
| Jose Augusto Roque | General Counsel · Since at least Apr 22, 2026 |
| Narain Duraiswami | Director · Since at least Dec 31, 2025 |
| Simon Vumbaca | Non-Executive Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Bioceres Crop Solutions Corp.